2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$24.46+$0.06 (+0.27%)
Price as of Oct 02, 2026 5:33 PM EDT- $2.5BMarket Cap
- -4.69%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$24.46+$0.06 (+0.27%)
BEAM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.39 | ||
Change | -$0.06 (-0.25%) | ||
Open | $24.24 | ||
High | $24.98 | ||
Low | $23.95 | ||
Previous Close | $24.45 | ||
Volume | 1,695,437 | ||
30-Day Average Volume | 1,940,035 | ||
1-Week Change | -1.09% | ||
1-Month Change | -15.95% | ||
1-Year Change | -4.69% | ||
3-Year Change | 1.41% | ||
5-Year Change | -71.76% | ||
Fundamentals | |||
Shares Outstanding | 103.3M | ||
Total Assets | $1.4B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $490,000.00 | ||
Net Income | -$122.7M | ||
Free Cash Flow | -$68.5M | ||
EBIT | -$120.0M | ||
EBITDA | -$114.6M | ||
Net Working Capital | $1.1B | ||
EPS | -$1.18 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 4,897 | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | 1 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/04/2014 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue